Policyholder Services



Will OMIC cover me for the intravitreal injection of kenalog?

Yes. Although the use of Kenalog has been FDA approved only for intramuscular administration, intra-articular administration, and administration within a tendon sheath, this steroid is routinely used on an off-label basis by ophthalmologists. Provided that the indication of the injection (whether subconjunctivally, subTenon, into the lid, or intravitreally) is appropriate and the physician is properly trained and experienced, OMIC will extend coverage for the insured’s use of Kenalog.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

#6. Supporting your specialty.

OMIC was founded by members of the American Academy of Ophthalmology nearly a quarter century ago and is the only carrier sponsored and endorsed by AAO. OMIC is also endorsed by 40 other ophthalmic societies. The OMIC partnerships with state and subspecialty societies qualifies their members for an exclusive 8% premium credit. Contact your state society for details.

61864684